Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium

CompletedOBSERVATIONAL

Enrollment

314

Participants

Timeline

Start Date

October 7, 2015

Primary Completion Date

February 12, 2018

Study Completion Date

February 12, 2018

Conditions

Chronic Hepatitis C, Genotype 1 or 4

Interventions

DRUG

Ombitasvir/paritaprevir/ritonavir

Co-formulated tablet

DRUG

Dasabuvir

Tablet

DRUG

Ribavirin

Tablet